Beijing Wandong Medical Technology Co.,Ltd. (SHA:600055)
15.06
+0.41 (2.80%)
Apr 29, 2026, 3:00 PM CST
SHA:600055 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -278.85 | -227.86 | 157.35 | 188.54 | 175.37 | 183.19 | Upgrade
|
| Depreciation & Amortization | 44.1 | 44.1 | 38.88 | 36.43 | 34.7 | 37.23 | Upgrade
|
| Other Amortization | 5.03 | 5.03 | 3.67 | 3.93 | 4.26 | 3.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.08 | 0.08 | -0.12 | 0.3 | 1.79 | 0.24 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0.02 | 0.36 | 4.83 | 6.88 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.25 | -4.25 | -3.52 | -42.88 | -17.92 | -18.84 | Upgrade
|
| Provision & Write-off of Bad Debts | 26.04 | 26.04 | 17.23 | 6.26 | 22.99 | 17.23 | Upgrade
|
| Other Operating Activities | 80.78 | 51.17 | 11.54 | 5.17 | -9.3 | -0.3 | Upgrade
|
| Change in Accounts Receivable | -233.16 | -233.16 | -39.12 | 128.31 | -132.26 | -61.33 | Upgrade
|
| Change in Inventory | -442.85 | -442.85 | 135.14 | -121.08 | -84.7 | 46.75 | Upgrade
|
| Change in Accounts Payable | 598.35 | 598.35 | -92.38 | -6.01 | 193.54 | -118.93 | Upgrade
|
| Change in Other Net Operating Assets | 6.78 | 6.78 | -7.94 | 2.92 | 7.75 | - | Upgrade
|
| Operating Cash Flow | -273.33 | -251.95 | 218.25 | 208.22 | 185.41 | 89.72 | Upgrade
|
| Operating Cash Flow Growth | - | - | 4.82% | 12.30% | 106.64% | -82.75% | Upgrade
|
| Capital Expenditures | -77.08 | -99 | -38.62 | -17.13 | -14.05 | -11.85 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | 0.02 | 1.28 | 0.74 | 1.97 | 0.2 | Upgrade
|
| Investment in Securities | 324.7 | 274.32 | -1,498 | 66.01 | 140.39 | 146.3 | Upgrade
|
| Other Investing Activities | - | - | - | 10.34 | 21.88 | 20.45 | Upgrade
|
| Investing Cash Flow | 247.65 | 175.35 | -1,536 | 59.97 | 150.2 | 155.1 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -3.66 | Upgrade
|
| Total Debt Repaid | - | - | - | - | - | -3.66 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | - | -3.66 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 2,049 | - | Upgrade
|
| Common Dividends Paid | -91.4 | -91.4 | -91.4 | -84.37 | -70.31 | -69.66 | Upgrade
|
| Other Financing Activities | -6.2 | -5.96 | -4.91 | -2.42 | 46.01 | 9.57 | Upgrade
|
| Financing Cash Flow | -97.6 | -97.36 | -96.31 | -86.78 | 2,025 | -63.75 | Upgrade
|
| Foreign Exchange Rate Adjustments | -9.45 | -9.45 | 3.64 | 1.66 | 7.44 | -1.12 | Upgrade
|
| Net Cash Flow | -132.73 | -183.42 | -1,410 | 183.06 | 2,368 | 179.95 | Upgrade
|
| Free Cash Flow | -350.41 | -350.95 | 179.64 | 191.09 | 171.36 | 77.87 | Upgrade
|
| Free Cash Flow Growth | - | - | -6.00% | 11.51% | 120.05% | -84.33% | Upgrade
|
| Free Cash Flow Margin | -25.39% | -26.05% | 11.78% | 15.45% | 15.28% | 6.73% | Upgrade
|
| Free Cash Flow Per Share | -0.50 | -0.50 | 0.26 | 0.27 | 0.26 | 0.14 | Upgrade
|
| Cash Income Tax Paid | - | 23.98 | 48 | 56.35 | 71.55 | 87.55 | Upgrade
|
| Levered Free Cash Flow | -181.8 | -137.41 | 138.29 | 69.89 | 72.64 | 0.12 | Upgrade
|
| Unlevered Free Cash Flow | -181.01 | -136.62 | 139.32 | 70.68 | 73.56 | 1.06 | Upgrade
|
| Change in Working Capital | -146.3 | -146.3 | -6.8 | 10.1 | -31.3 | -138.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.